Loading...

XORTX Therapeutics Inc.

XRTX•NASDAQ
Healthcare
Biotechnology
$2.69
$0.44(19.56%)
U.S. Market opens in 8h 5m

XORTX Therapeutics Inc. (XRTX) Stock Overview

Explore XORTX Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap749.1K
P/E Ratio-0.25
EPS (TTM)$-2.80
ROE-1.11%
Fundamental Analysis

AI Price Forecasts

1 Month$0.37
3 Months$0.33
1 Year Target$0.00

XRTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of XORTX Therapeutics Inc. (XRTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 73.14, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.25 and a market capitalization of 749.1K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
19.56%
5-Day Change
21.17%
1-Month Change
35.86%
3-Month Change
-6.92%
6-Month Change
-25.69%
Year-to-Date (YTD) Change
-4.27%
1-Year Change
-38.16%
3-Year Change
-91.82%
5-Year Change
-96.49%
All-Time (Max) Change
-96.44%

Contact Information

https://www.xortx.com
+1 403 455 7727
421 – 7th Avenue SW, Vancouver, BC, T2P 4K9

Company Facts

2 Employees
IPO DateSep 23, 2021
CountryCA
Actively Trading

Frequently Asked Questions